Targeting Oncometabolism to Maximize Immunotherapy in Malignant Brain Tumors

Brain tumors result in significant morbidity and mortality in both children and adults. Recent data indicates that immunotherapies may offer a survival benefit after standard of care has failed for malignant brain tumors. Modest results from several late phase clinical trials, however, underscore th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstock, Joshua D., Kang, Kyung-Don, Klinger, Neil V., Olsen, Hannah E., Gary, Sam, Totsch, Stacie K., Ghajar-Rahimi, Gelare, Segar, David, Thompson, Eric M., Darley-Usmar, Victor, Mott, Bryan T., Peruzzotti-Jametti, Luca, Friedman, Gregory K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081266/
https://www.ncbi.nlm.nih.gov/pubmed/35430605
http://dx.doi.org/10.1038/s41388-022-02312-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081266/
https://www.ncbi.nlm.nih.gov/pubmed/35430605
http://dx.doi.org/10.1038/s41388-022-02312-y

Ejemplares similares